Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CF versus DCF induction chemotherapy in locally advanced head and neck cancer
ISRCTN08658578Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cisplatin, fluorouracil and docetaxel in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Tumor response. Started Jul 2009; status: completed.
02
Drugs
cisplatinfluorouracildocetaxel
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on ISRCTN08658578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN08658578.